Under construction – not a live service
Sign in
Taking people in FranceNo phase

Smartphone App Screens for Sleep Apnea in Head and Neck Cancer Patients

Tests a smartphone app for sleep apnea in adults with head and neck lesions.

Key facts

Who runs it
University Hospital, Caen
Where
Caen, FranceSee the site
Trial code
Registry title
Innovative OSA Screening in Head and Neck Cancer Patients With the Apneal App
Status
Recruiting
People taking part
20 people, planned
Started
16 Sept 2025
Expected to end
16 Sept 2027
Type of study
Interventional
Treatments tested
  • Specialized sleep consultation and overnight recording using the APNEAL application
Record updated
18 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a head and neck lesion that is confirmed as cancer. It tests a smartphone app that checks for sleep apnea during their care.

Age
Adults, 18 years or older.
Sex
All sexes can join.
Disease stage
Confirmed malignant (cancerous) head and neck lesion in the nasopharynx, nasal cavities, sinuses, oral cavity, oropharynx, hypopharynx, larynx or parotid gland. Metastatic cancer is not allowed.
Earlier treatment
People with previously treated head and neck cancer cannot join.

Main reasons for not taking part

  • Under 18, or under judicial protection, guardianship or curatorship
  • Malignant nature of the lesion not confirmed
  • Diagnosis of metastatic cancer
  • Known history of obstructive sleep apnea syndrome (OSAS)
  • Previously treated head and neck cancer

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Adult patients undergoing diagnostic workup for a lesion suspected to be a head and neck cancer, followed by confirmation of the malignant nature of the lesion. The following locations will be included: the nasopharynx, nasal cavities, sinuses, oral cavity, oropharynx, hypopharynx, larynx, and parotid gland
  • The collection of the informed consent signature is required
  • The patient must be affiliated with the social security system

Who cannot take part

  • Known history of obstructive sleep apnea syndrome (OSAS) or previously treated head and neck cancer
  • Lack of confirmation of the malignant nature of the lesion
  • Diagnosis of metastatic cancer
  • Minor patients, or those under judicial protection, guardianship, or curators

Where in France

  • CHU CaenCaen, FranceContact: BALUTA Lisa, internTaking people

About the trial

What the trial wants to find out

Obstructive sleep apnea syndrome is a common but often underdiagnosed condition, with significant impacts on quality of life, such as fatigue, attention disorders, and an increased risk of heart attack or stroke. Structural changes in the head and neck region appear to contribute to the onset or worsening of this condition.

Read full original descriptionShow less

To improve patients' quality of life, early diagnosis is essential. Currently, diagnosis relies on expensive devices, often associated with long waiting times. To address these challenges, an innovative solution is proposed: a smartphone application enabling a simple and accessible diagnosis. This application is currently under validation and has not yet been commercialized.

The purpose of the study is to determine whether this smartphone application can be used in clinical practice for patients with a head and neck lesion to diagnose sleep apnea syndrome and to assess its progression during the medical care. This study is for patients who present a head and neck lesion currently under evaluation in our department at Caen University Hospital.

This research will be integrated into routine follow-up for a period of six months.

The medical device used in this study, Apneal, is a smartphone application currently undergoing validation for the rapid diagnosis of sleep apnea syndrome. Its use is simple: the smartphone is placed in airplane mode and secured to the chest overnight. Using the phone's built-in sensors, respiratory sleep data is collected and analyzed.

As part of the initial assessment, a dedicated sleep consultation is included, during which a few questionnaires are completed, followed by an overnight sleep recording using the Apneal application. This will be conducted at the beginning of the care during the assessment phase and again six months after the completion of any potential treatment.

Depending on the results, if they are inconclusive, an additional sleep recording may be required using a ventilatory polygraphy device.

This study involves only two overnight recordings with a smartphone secured to the chest, which we will set up during the consultation.

The group in the trial

  • Patients with head and neck cancersTreatment being tested

    Treatment: Specialized sleep consultation and overnight recording using the APNEAL application

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Innovative OSA Screening in Head and Neck Cancer Patients With the Apneal App
Plain-language title
Smartphone App Screens for Sleep Apnea in Head and Neck Cancer PatientsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
18 June 2026